According to the latest report by IMARC Group, titled “Poultry Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the globalreached a value of US$ 1.67 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.47 Billion by 2027, exhibiting at a CAGR of 6.59% during 2022-2027.
Poultry disease refers to an infectious animal disease affecting various poultry species, including chicken, turkey, duck, goose, etc. It causes diarrhea, facial edema, twisting of the neck, paralysis of wings and legs, cyanosis of comb, reduced egg production, sudden death, etc. Consequently, poultry animals undergo vaccination to boost their immunity and produce antibodies, which can inactivate pathogens.
Poultry vaccines also aid in preserving the health of these animals by functioning as a preventive measure against the outbreak of contagious diseases. Presently, they can be administered via injections, feed, eye-drop, drinking water, etc.
Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.
Download a free sample report to get a detailed overview of the market:
The escalating prevalence of zoonotic diseases, such as avian influenza and bird flu, is one of the primary factors driving the poultry vaccines market. Furthermore, the increasing demand for animal disease diagnostics and treatments is also catalyzing the market growth. Besides this, the growing consumption of animal-derived products and the rising concerns towards food safety are further augmenting the global market.
Moreover, several leading market players are investing in research and development (R&D) activities for introducing advanced poultry vaccines to help in protecting animals against infectious bursal diseases, infectious bronchitis, virulent Newcastle disease (VND), etc., which is also bolstering the market growth. In addition to this, the introduction of non-replicating recombinant antigens and live-gene detected vaccines is expected to stimulate the poultry vaccines market over the forecasted period.
Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global poultry vaccines market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- AniCon Labor GmbH (SAN Group)
- Biovac Ltd.
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Hester Biosciences Limited
- Merck & Co. Inc.
- Phibro Animal Health Corporation
- Venkys India
- Zoetis Inc.
Key Market Segmentation:
The report has segmented the global poultry vaccines market on the basis of disease, product, type, dosage form, application, end user and region.
Breakup by Disease:
- Infectious Bronchitis
- Avian Influenza
- Newcastle Disease
- Marek’s Disease
Breakup by Product:
- Recombinant Vaccine
- Live Attenuated Vaccine
- Inactivated Vaccine
- Subunit Vaccine
Breakup by Dosage Form:
- Liquid Vaccine
- Freeze Dried Vaccine
Breakup by Application:
Breakup by End User:
- Veterinary Hospitals
- Poultry Firm
- Poultry Vaccination Center
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Industry Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Commercial Display Market Exclusive Report 2022-2027:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800